You’ve spent months on your yeast display campaign. You identified a panel of high-affinity binders. But when you moved your top candidate into mammalian expression for characterization, the results were disappointing: poor protein expression and 50% aggregation.
For years, the field has debated yeast display vs. mammalian display as if they were competitors. The truth is, they are specialized partners.
Use yeast for what it is best at: raw discovery. Then, use mammalian for what it is best at: validation and developability.
Yeast Display as the Discovery Engine
Massive Numbers: Yeast display libraries routinely achieve 10^7-10^9 diversity, providing exceptional statistical power for identifying rare binding events.
Robustness and Speed: Fast growth, easy handling, stable and uniform display make yeast the workhorse for iterative rounds of selection.
Pure Affinity Readout: The yeast system provides a clean selection focused on binding affinity and specificity, without the confounding effects of mammalian-specific post-translational modifications.
The recommended approach: 3-4 rounds of high-stringency sorting, then use NGS to identify the entire enriched polyclonal pool rather than cherry-picking individual clones.
Mammalian Display as the “Developability Matrix”
The question shifts from “Can it bind?” to “Of these 10,000 great binders, which ones can actually be manufactured?”
Yeast cannot determine: correct folding in CHO cells, human-like post-translational modifications and glycosylation patterns, or stability at high concentrations required for therapeutic formulation.
Four-Step Workflow
-
Create a Focused “Hits Library”. Synthesize 1,000-10,000 hits identified from yeast display NGS data as a focused sub-library.
-
Screen in Mammalian Display. Transfect the focused library into HEK or CHO cells using CRISPR integration or lentiviral delivery for single-copy, uniform expression.
-
Run the “Developability Sort”. Stain cells with antibodies against expression tags (c-myc or HA) to quantify surface display levels in the mammalian context.
-
Sort for the Brightest Cells. Collect the top 5-10% with the highest expression signal.
This simple sort is what I call “Developability Matrixing.” You are running your panel of high-affinity hits through a matrix that filters for one thing: recombinant protein expression and stability in a manufacturing-relevant host.
The Payoff
A candidate with high affinity in yeast and high expression in mammalian display represents prospective selection for:
- High function (from yeast display screening)
- High developability (from mammalian display filtering)
This approach “shifts left” on developability, moving critical late-stage failure points to early discovery phases where they cost orders of magnitude less to address.
Related Ranomics services
- Yeast surface display services: Affinity-focused primary screening on yeast.
- Mammalian display: Developability-focused secondary screening with proper post-translational modifications.
Frequently asked questions
What is the two-platform approach to antibody discovery?
The two-platform approach uses yeast display and mammalian display as sequential partners rather than competitors. Yeast display runs primary discovery, generating and enriching high-affinity binders fast from libraries of 10^7 to 10^9. Mammalian display then screens those hits for developability, filtering out variants that fail expression or folding in a manufacturing-relevant host before commitment to scale-up.
Why use both yeast display and mammalian display?
Yeast display is the discovery engine: large library sizes, fast iteration, and a clean affinity readout. It cannot assess correct folding in CHO cells, human-like glycosylation, or stability at therapeutic formulation concentrations. Mammalian display answers those questions. Running them in sequence catches developability failures during early discovery, where they cost orders of magnitude less to fix than at late-stage characterization.
How does the two-platform display workflow work?
After yeast display selection, NGS identifies the enriched polyclonal pool and a focused hits library of 1,000 to 10,000 candidates is synthesized. That library is transfected into HEK or CHO cells with single-copy integration, stained for surface display level, and sorted for the brightest 5 to 10 percent. A candidate with high yeast affinity and high mammalian expression is selected for both function and developability.